Capital expenditure increased 118.8%
Capital expenditure changed +118.8% from the comparable as-filed period. The change ranks at the 100th percentile of 6 prior comparable changes.
$441,000→$965,0006 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →PD financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents decreased 43.8%
Cash & equivalents changed -43.8% from the comparable as-filed period.
$371.8M→$208.9M2 prior comparisons
Free-cash-flow proxy increased 43.3%
Free-cash-flow proxy changed +43.3% from the comparable as-filed period. The change ranks at the 67th percentile of 6 prior comparable changes.
$30.2M→$43.3M6 prior comparisons
Net income increased 173.8%
Net income changed +173.8% from the comparable as-filed period.
-$7.2M→$5.3M3 prior comparisons
Operating cash flow increased 44.4%
Operating cash flow changed +44.4% from the comparable as-filed period. The change ranks at the 67th percentile of 6 prior comparable changes.
$30.7M→$44.3M6 prior comparisons
Operating income increased 188.9%
Operating income changed +188.9% from the comparable as-filed period.
-$10.3M→$9.2M3 prior comparisons
Operating margin moved 1621 bp higher
Operating margin changed +1621 basis points from the comparable as-filed period.
-8.62%→7.59%3 prior comparisons
Stock-based compensation decreased 30.2%
Stock-based compensation changed -30.2% from the comparable as-filed period.
$25.8M→$18.0M3 prior comparisons
Capex / revenue moved 43 bp higher
Capex / revenue changed +43 basis points from the comparable as-filed period.
0.37%→0.80%2 prior comparisons
Research & development decreased 11.9%
Research & development changed -11.9% from the comparable as-filed period.
$34.0M→$30.0M3 prior comparisons
Gross margin moved 29 bp higher
Gross margin changed +29 basis points from the comparable as-filed period.
83.99%→84.28%3 prior comparisons
Gross profit increased 1.3%
Gross profit changed +1.3% from the comparable as-filed period.
$100.6M→$101.9M3 prior comparisons
Revenue increased 1.0%
Revenue changed +1.0% from the comparable as-filed period.
$119.8M→$121.0M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.